Epithelial-to-mesenchymal transition (EMT) is critical for lung carcinogenesis and observation of a malignant phenotype, and inhibition of COX-2 reverses EMT-induced changes in lung cancer patients (Dohadwala et al., 2006; Peebles et al., 2007). The gene discussed is PTGS2; the disease is lung cancer.